Stereotaxis Inc
NYSE-MKT:STXS
Stereotaxis Inc
NYSE-MKT:STXS
Price:
1.92 USD
Market Closed
Updated:
Jun 6, 2024
Stereotaxis Inc
Operating Expenses
|
Stereotaxis Inc
Operating Expenses Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Stereotaxis Inc
NYSE-MKT:STXS
|
Operating Expenses
-$35.9m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
0%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Operating Expenses
-$5.9B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-7%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Operating Expenses
-$7.7B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-7%
|
|
|
Stryker Corp
NYSE:SYK
|
Operating Expenses
-$8.9B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Operating Expenses
-$15.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-7%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Expenses
-$3B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-14%
|
See Also
What is Stereotaxis Inc's Operating Expenses?
Operating Expenses
-35.9m
USD
-35.9m
USD
Based on the financial report for Mar 31, 2024, Stereotaxis Inc's Operating Expenses amounts to -35.9m USD.
What is Stereotaxis Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
0%
0%
Over the last year, the Operating Expenses growth was 5%. The average annual Operating Expenses growth rates for Stereotaxis Inc have been -11% over the past three years , -6% over the past five years .
You don't have any saved screeners yet
